Knoxville, TN3 Active Studies

Myalgic Encephalomyelitis Clinical Trials in Knoxville, TN

Find 3 actively recruiting myalgic encephalomyelitis clinical trials in Knoxville, TN. Connect with local research sites and explore new treatment options.

3
Active Trials
3
Sponsors
380
Enrolling

Recruiting Myalgic Encephalomyelitis Studies in Knoxville

About Myalgic Encephalomyelitis Clinical Trials in Knoxville

Myalgic encephalomyelitis (ME/CFS) is a complex, chronic illness characterized by profound fatigue, post-exertional malaise, cognitive impairment, and sleep dysfunction. It affects millions worldwide and has no definitive diagnostic test or cure. Research is exploring immune, metabolic, and neurological mechanisms.

There are currently 3 myalgic encephalomyelitis clinical trials recruiting participants in Knoxville, TN. These studies are seeking a combined 380 participants. Research is being sponsored by Regeneron Pharmaceuticals, Shionogi, The University of Tennessee, Knoxville. Clinical trial participation is free and participants receive study-related medical care at no cost.

Myalgic Encephalomyelitis Clinical Trials in Knoxville — FAQ

Are there myalgic encephalomyelitis clinical trials in Knoxville?

Yes, there are 3 myalgic encephalomyelitis clinical trials currently recruiting in Knoxville, TN. Browse the studies on this page to find one that fits.

How do I join a clinical trial in Knoxville?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Knoxville research site will contact you about next steps.

Are clinical trials in Knoxville free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Knoxville studies also compensate for your time and travel.

What myalgic encephalomyelitis treatments are being tested?

The 3 active trials in Knoxville are testing new therapies including novel drugs, biologics, and treatment approaches for myalgic encephalomyelitis.

Data updated July 13, 2026 from ClinicalTrials.gov